Apr 15, 2025 05:45 AM IST
Since returning to the White Home, Trump has unleashed sweeping tariffs on US buying and selling companions – hitting imports from China with particularly stiff charges.
The US has opened the door to potential tariffs focusing on prescribed drugs and semiconductor imports, in accordance with authorities filings Monday, shortly after President Donald Trump warned current tech exclusions would solely be short-term.
The Commerce secretary has initiated a pair of investigations into the nationwide safety results of imports of prescribed drugs and elements, in addition to semiconductors and chip-making tools, in accordance with filings to the Federal Register.
The probes had been launched below Part 232 of the Commerce Enlargement Act, in accordance with the filings, and this was the identical authorized mechanism that Trump beforehand used to impose different sector-specific duties.
Since returning to the White Home in January, Trump has unleashed sweeping tariffs on US buying and selling companions — hitting imports from China with particularly stiff charges.
He has additionally imposed a collection of sector-specific levies, not too long ago slapping tariffs on imports of metal, aluminum and autos.
The Commerce Division’s newest filings name for public touch upon pharma and semiconductors imports.
This consists of the influence of present commerce insurance policies on home semiconductor manufacturing and capability, and whether or not further measures like tariffs or quotas may be “crucial to guard nationwide safety.”
